期刊文献+

Mirabijalone-B的抗肿瘤效应及对DNA拓扑异构酶的影响 被引量:7

Antitumor activity of compound Mirabijalone B and its effect on DNA topoisomerases
下载PDF
导出
摘要 目的研究化合物Mirabijalone-B(MB)的抗肿瘤活性及对DNA拓扑异构酶(TOPO)活性的影响。方法以5株人肿瘤细胞株为模型,采用改良MTT法检测化合物MB的体外抗肿瘤活性;以质粒pBR322超螺旋DNA为底物,采用凝胶电泳分别检测MB对TOPOⅠ、Ⅱ介导的pBR322DNA解旋反应的影响。结果化合物MB对5株人肿瘤细胞株K562、HL-60、A549、Bel-7402和SGC-7901生长增殖的半数抑制浓度(IC50)分别为8.73、1.26、4.44、1.93和3.55mg.L-1;MB在80和16mg·mL-1浓度时,分别完全抑制TOPOⅠ、Ⅱ介导的pBR322超螺旋DNA的解旋反应;但在无TO-PO存在的条件下,MB对pBR322超螺旋DNA的解旋反应无直接影响。结论化合物MB体外明显抑制人肿瘤细胞的生长增殖,对DNATOPO尤其是TOPOⅡ活性的抑制可能是其抗肿瘤作用的机制之一。 Aim To investigate the antitumor effect of mirabijalone B (MB) isolated from Mirabilis jalapa L and its effect on DNA topoisomerases. Methods The cytotoxicity of MB on the five human tumor cell lines was detected by modified MTT assay in vitro. The effects of MB on topoisomerase (topo)-mediated pBR322 DNA relaxation and on pBR322 DNA relaxation in absence of TOPO were measured by using agarose gel electrophoresis. Results Compound MB showed an obvious cytotoxicity, the IC50 for five hmnan tumor cell lines--K562, HL-60, A549, Bel-7402 and SGC-7901 were 8.73, 1.26, 4.44,1.94 and 3.55 mg · L^-1 , respectively. At the Concentrations of 80 and 16 mg· L^-1, MB completely inhibited the pBR322 DNA relaxation mediated by TOPO I and TOPO Ⅱ , respectively, but it had no direct effect on pBR322 DNA relaxation in absence Of TOPO. Conclusions Compound MB has antitumor activity against human tumor cell lines in vitro, and the inhibitory effect of MB on DNA TOPO activity, especially on TOPO Ⅱ may be the one of its mechanisms of action.
出处 《中国药理学通报》 CAS CSCD 北大核心 2009年第10期1345-1349,共5页 Chinese Pharmacological Bulletin
基金 云南省自然科学基金资助项目(No2000C001P) 科技部和云南省国际合作资助项目(No2005DFA30670 2008AC002)
关键词 紫茉莉 鱼藤酮类化合物 Mirabijalone-B 人肿瘤细胞株 细胞毒活性 DNA拓扑异构酶 Mirabilis jalapa L rotenone Mirabijalone-B human tumor cell lines cytotoxicity DNA topoisomerase
  • 相关文献

参考文献15

  • 1Tan R X,Zheng W F,Tang H Q.Biologically active substances from the genus Artemisia[J].Planta Med,1998,64:295-2.
  • 2侯宽昭.中国种子植物科属词典[M].北京:科学出版社,1998.1-632.
  • 3Mohammad SA,Abdul R,Jamal M,et al.An 8-hydroxyoctadeca-cis-11,14-dienoic acid from Mirabilis jalapa seed oil[J].Phytochemistry,1984,23:2247-9.
  • 4Ghosh T K,Rao C C.Some structural features of the D-glucan from the seed of Mirabilis jalapa[J].Carbohydr Res,1981,90:243-50.
  • 5Yang S W,Ubillas R,McAlpine J,et al.Three new phenolic compounds from a manipulated plant cell culture,Mirabilis jalapa[J].J Nat Prod,2001,64:313-7.
  • 6李娟好,李明亚,张德志,黄小则.紫茉莉根水提物降血糖作用的研究[J].广东药学院学报,2006,22(3):299-299. 被引量:15
  • 7王峻,崔学教,柯玉诗,黄庆,陈铭,谢建兴,姚建武.紫花茉莉抗实验性前列腺增生的作用观察[J].广州中医药大学学报,2005,22(5):393-395. 被引量:2
  • 8Vivanco J M,Querci M,Salazar L F.Antiviral and antiviroid activity of MAP -containing extracts from Mirabilis jalapa roots[J].Plant Dis,1999,83,1116-21.
  • 9Wang Y F,Chen J J,Yang Y,et al.New rotenoids from roots of mirabilis jalapa[J].Helvetica Chimica Acta,2000,85:2342-8.
  • 10De Isabella P,Capranico G,Binashi M,et al.Evidence of DNA topoisomerase Ⅱ-dependent mechanisms of multidrug resistance in P388 leukemia cells[J].Mol Phamacol,1990,37(1):11-6.

二级参考文献30

共引文献218

同被引文献90

引证文献7

二级引证文献75

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部